Precipio, Inc.PRPOEarnings & Financial Report
Nasdaq · Health Care · Laboratory Analytical Instruments
Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. OF ABOVE PERSONS | 5.73% | 84.3K | — | 2024-08-02 |
Insider Transactions
Net 90d: +$531 · buys $531 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-15 | Jeffrey Cossman | Director | Grant | 365 | $29.49 | $10.8K |
| 2026-04-15 | Valauri Christina Rizopoulos | Director | Grant | 93 | $29.49 | $2.7K |
| 2026-04-15 | Cohen David Seth | Director | Grant | 445 | $29.49 | $13.1K |
| 2026-04-01 | Sabet Ahmed Zaki | Chief Operating Officer | Buy (open market) | 19 | $27.93 | $531 |
1–4 of 4